Episode Details
Back to Episodes
RNA-triggered CRISPR kill switch & Hidden microproteins in human biology - News (May 7, 2026)
Published 2 weeks ago
Description
Please support this podcast by checking out our sponsors:
- Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad
- SurveyMonkey, Using AI to surface insights faster and reduce manual analysis time - https://get.surveymonkey.com/tad
- Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily
Support The Automated Daily directly:
Buy me a coffee: https://buymeacoffee.com/theautomateddaily
Episode Transcript
RNA-triggered CRISPR kill switch
In medical research, scientists are reporting a powerful new way to selectively eliminate cells using CRISPR—by listening for RNA, not just targeting DNA. The enzyme, called Cas12a2, can be programmed so it only activates when it detects a chosen RNA transcript inside a cell. Once triggered, it essentially shreds DNA broadly, creating overwhelming damage that pushes cells toward shutdown and death. In tests, human cancer cells without the target RNA were largely spared, and the researchers say they saw little evidence of unintended activation under their conditions. As proof of concept, they targeted HPV cancer transcri
- Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad
- SurveyMonkey, Using AI to surface insights faster and reduce manual analysis time - https://get.surveymonkey.com/tad
- Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily
Support The Automated Daily directly:
Buy me a coffee: https://buymeacoffee.com/theautomateddaily
Today's topics:
RNA-triggered CRISPR kill switch - Researchers showcased Cas12a2, an RNA-activated CRISPR “kill switch” that destroys DNA only when a specific transcript is present, enabling selective cell elimination in cancer and antiviral work.
Hidden microproteins in human biology - Scientists mapping the “dark proteome” found many overlooked microproteins from regions once labeled noncoding, revealing new biology tied to mitochondria, DNA repair, and cancer targets.
Pancreatic cancer drug survival boost - Early Phase 3 data suggest daraxonrasib plus chemotherapy may roughly double overall survival in advanced pancreatic cancer, with FDA fast-track and notable side effects under close review.
Europe moves to secure Hormuz - France is repositioning the Charles de Gaulle carrier strike group toward the Red Sea for a potential French-British defensive mission tied to restoring shipping confidence near the Strait of Hormuz and oil supply stability.
Russia’s alleged hit plots in Europe - Western intelligence officials say Russia has expanded attempted targeted killings across Europe using proxies, aiming to intimidate activists and disrupt countries backing Ukraine.
China’s mass adoption of agentic AI - China is becoming a large-scale real-world testing ground for generative and agentic AI, with hundreds of millions of users and rapid integration into daily life and business workflows.
Meta sued over AI training data - A class-action lawsuit from author Scott Turow and major publishers accuses Meta of training Llama models on pirated books and papers, testing legal boundaries of AI ‘fair use’ versus infringement.
Deepfakes escalate election and scam risks - Experts warn realistic AI deepfakes are spreading faster than enforcement and public detection, raising risks for elections, schools, and everyday impersonation scams.
Alphabet nears top market value - Alphabet is closing in on Nvidia’s top market-cap spot as Google Cloud growth and AI strategy excite investors, signaling a shift toward companies monetizing AI at platform scale.
Episode Transcript
RNA-triggered CRISPR kill switch
In medical research, scientists are reporting a powerful new way to selectively eliminate cells using CRISPR—by listening for RNA, not just targeting DNA. The enzyme, called Cas12a2, can be programmed so it only activates when it detects a chosen RNA transcript inside a cell. Once triggered, it essentially shreds DNA broadly, creating overwhelming damage that pushes cells toward shutdown and death. In tests, human cancer cells without the target RNA were largely spared, and the researchers say they saw little evidence of unintended activation under their conditions. As proof of concept, they targeted HPV cancer transcri